Intrathecal B-Cell Clonal Expansion, an Early Sign of Humoral Immunity, in the Cerebrospinal Fluid of Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

The development of somatically mutated memory and plasma B cells is a consequence of T cell-dependent antigen-challenged humoral immunity. To investigate the role of B cell-mediated humoral immunity in the initiation and evolution of multiple sclerosis (MS), we analyzed Ig variable heavy chain genes of intrathecal B cells derived from patients with a first clinical manifestation suggestive of MS. Sequences of Ig variable regions showed that B cells in the cerebrospinal fluid from most of these patients were clonally expanded and carried somatic hypermutated variable heavy chain genes. The mutations showed a high replacement-to-silent ratio and were distributed in a way suggesting that these clonally expanded B cells had been positively selected through their antigen receptor. In comparison, intrathecal B-cell clonal expansion often precedes both oligoclonal IgG bands and multiple magnetic resonance imaging lesions. Clinical follow-up study showed that patients with clonally expanded intrathecal B cells had a high rate of conversion to clinically definite MS. The findings provide direct evidence of recruitment of germinal center differentiated B lymphocytes into the central nervous system during the initiation of MS. These results indicate B cell-mediated immune response in the cerebrospinal fluid is an early event of inflammatory reaction in the central nervous system of MS. This procedure also provides a more sensitive method to evaluate the association of humoral immunity in the evolution of MS.

[1]  J. Correale,et al.  Oligoclonal bands and antibody responses in Multiple Sclerosis , 2002, Journal of Neurology.

[2]  A. Cross,et al.  Oligoclonal band number as a marker for prognosis in multiple sclerosis. , 2001, Archives of neurology.

[3]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[4]  A. Cross,et al.  B cells and antibodies in CNS demyelinating disease , 2001, Journal of Neuroimmunology.

[5]  Jane E Petty Multiple Sclerosis in Clinical Practice , 2000 .

[6]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[7]  H. Hartung,et al.  The role of B cells and autoantibodies in multiple sclerosis , 2000, Annals of neurology.

[8]  A. Cross MS: The return of the B cell , 2000, Neurology.

[9]  N. Chiorazzi,et al.  Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients1 , 2000, The Journal of Immunology.

[10]  Ganter,et al.  Spinal cord axonal loss in multiple sclerosis: a post‐mortem study , 1999, Neuropathology and applied neurobiology.

[11]  S. Baranzini,et al.  B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. , 1999, Journal of immunology.

[12]  N. Holland Multiple Sclerosis in Clinical Practice , 1999 .

[13]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[14]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[15]  K. Kuma,et al.  The Complete Nucleotide Sequence of the Human Immunoglobulin Heavy Chain Variable Region Locus , 1998, The Journal of experimental medicine.

[16]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[17]  Y. Qin,et al.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. , 1998, The Journal of clinical investigation.

[18]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[19]  D. Gilden,et al.  Restricted use of VH4 Germline segments in an acute multiple sclerosis brain , 1998, Annals of neurology.

[20]  J. Strominger,et al.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. , 1997, The Journal of clinical investigation.

[21]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[22]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[23]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[24]  H. Müller-Hermelink,et al.  Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. , 1995, Blood.

[25]  H. McFarland,et al.  Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions , 1993, Annals of neurology.

[26]  D. Bahler,et al.  Clonal evolution of a follicular lymphoma: evidence for antigen selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Nossal,et al.  The molecular and cellular basis of affinity maturation in the antibody response , 1992, Cell.

[28]  D. Gray,et al.  B-cell memory is short-lived in the absence of antigen. , 1991, Nature.

[29]  J. Macartney,et al.  Reduced apoptotic cell death in follicular lymphoma , 1991, The Journal of pathology.

[30]  I. Maclennan,et al.  Mechanism of antigen-driven selection in germinal centres , 1989, Nature.

[31]  A. Campbell,et al.  IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS , 1989, Neuropathology and applied neurobiology.

[32]  D. Gray,et al.  T cell memory is short-lived in the absence of antigen , 1988, Nature.

[33]  T. Kunkel,et al.  Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. , 1988, Biochemistry.

[34]  D. Allen,et al.  Antibody engineering for the analysis of affinity maturation of an anti‐hapten response. , 1988, The EMBO journal.

[35]  D. Pisetsky,et al.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Kocks,et al.  Timing, Genetic Requirements and Functional Consequences of Somatic Hypermutation during B‐Cell Development , 1987, Immunological reviews.

[37]  Klaus Rajewsky,et al.  Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses , 1987, Cell.

[38]  E. Reinherz,et al.  In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. , 1985, The New England journal of medicine.

[39]  C. Milstein,et al.  Somatic mutation and the maturation of immune response to 2-phenyl oxazolone , 1984, Nature.

[40]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[41]  J. L. King,et al.  Evolutionary nucleotide replacements in DNA , 1979, Nature.

[42]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Henry A. Erlich,et al.  The polymerase chain reaction. , 1989, Trends in genetics : TIG.

[44]  ichard,et al.  AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .

[45]  E. Oberfield,et al.  Electroblot analysis of rat myelin proteolipid protein and basic protein during development. , 1983, Developmental neuroscience.